After two successful years of bringing the world’s leading authorities on energy and environmental issues together for a day of intelligent exchange on the changing landscape of energy markets, conservation efforts, and alternatives to fossil fuels, The Atlantic expanded its Green Intelligence Forum to two days in 2010.
The Atlantic's 2010 Green Intelligence Forum dedicated a full day to Green Energy and Sustainability, looking at supply-chain and manufacturing issues as well as the energy market itself. The following morning, the Forum built upon the foundation laid at the The Atlantic's 2009 Water Summit, exploring the nexus of water and energy as well as water quality and development policy.
As always, The Atlantic drew upon a wide range of professions and 360º points of view to facilitate a penetrating, lively, and illuminating two days of conversation.
In case you missed the livestream of the event, video of all the panels and headline interviews are below:
DAY 1 VIDEOS
Welcome and Intro
Interview with David Hayes plus 'Powering the Future, Sustainably' panel
'The Path to a Low Carbon World' panel plus 'What Green Means to Industry' panel
'Environmental Competitiveness' panel plus Keynote by Bill Ritter
DAY 2 VIDEOS
Interview with Melody Barnes plus 'The Future of Fresh Water' panel
'Moving Towards Clean Transportation' panel plus Keynote by David Sandalow
'Innovations in Global Transport' panel plus Keynote by John Holdren
For its ninth year, the Washington Ideas Forum will convene the nation's leaders, from politics and government to business and culture for two days of idea sharing and thought provoking conversation.
Cracking the Code: The Next Generation of Women in STEM
In this Atlantic summit, we will bring together the leading educators, thought leaders, students and creators re-thinking from the ground up what it means to raise and become a woman in STEM.
At What Cost?
An Atlantic Forum on Prescription Drugs
The Atlantic will convene top health policy thinkers and practitioners to explore how to foster drug innovation while controlling cost with new approaches like value-based programs on the horizon.